04403nam 2201081z- 450 991056647940332120220506(CKB)5680000000037586(oapen)https://directory.doabooks.org/handle/20.500.12854/81230(oapen)doab81230(EXLCZ)99568000000003758620202205d2022 |y 0engurmn|---annantxtrdacontentcrdamediacrrdacarrierRare Respiratory Diseases: A Personal and a Public Health ProblemBaselMDPI - Multidisciplinary Digital Publishing Institute20221 online resource (242 p.)3-0365-3669-8 3-0365-3670-1 Dear Colleagues, A rare disease, also known as an orphan disease, is any disease that affects a small percentage of the population. Although definitions vary from continent to continent, according to the European Union, rare diseases are those with a prevalence of less than 1 in 2000 people. Rare diseases are, in general, chronic, debilitating diseases, which in many cases threaten patients' lives. It is estimated that 1-2 million people in the European Union are affected by a rare respiratory disease, which is a public health problem. Due to the low prevalence and severity of many of these diseases, whose symptoms often initially manifest in childhood, combined efforts are needed to improve our knowledge of the pathophysiology of these diseases that will lead to the development of new, more effective treatments. Therefore, since rare respiratory diseases represent an important field in medicine, we propose this Special Issue to promote the dissemination of the latest advances in basic and clinical research in these diseases. Prof. Dr. Francisco Dasí Guest EditorRare Respiratory DiseasesMedicine and NursingbicsscPharmacologybicsscactive lifestyleALI culturealpha-1 antitrypsin deficiencyAlpha-1 antitrypsin deficiencyalpha-1-antitrypsin deficitalpha1 antitrypsin deficiencyalpha1-antitrypsin deficiencyantibodyantioxidant therapiesasthmaaugmentation therapybio-resourcebronchiectasischronic obstructive pulmonary diseaseciliaclinical presentationcystic fibrosisdiagnosticsemphysemaendoplasmic reticulum stressexhaled breath condensateflow cytometrygamma-glutamyl transpeptidasegene therapyglutamate-oxaloacetate transaminaseglutamate-pyruvate transaminaseidiopathic pulmonary fibrosisimmunofluorescenceinfection control measurelaterality defectliver diseasemiRNA expressionMycobacterium aviumMycobacterium intracellularen/anasal epitheliumneonatal respiratory distressnodular bronchiectasisnon-tuberculous mycobacteriaorphan diseasesoxidative stressPCDprimary ciliary dyskinesiaprimary nasal epitheliumpulmonary aspergillosispulmonary exacerbationrare diseasesrare pulmonary diseaserare respiratory diseasesreactive oxygen speciesreference centresreplacement therapyresilienceself-quarantineseveritysputumstandard diagnosisstress levelstransient elastographyMedicine and NursingPharmacologyDasí Franciscoedt1303404Dasí FranciscoothBOOK9910566479403321Rare Respiratory Diseases: A Personal and a Public Health Problem3027003UNINA